Instem

Instem, established in 1969 in the United Kingdom, provides SaaS platforms and services for life sciences organizations, supporting drug research and development. Their solutions span in silico data insights, study management, regulatory submission, and clinical trial analytics, used by over 700 clients worldwide.

Instem was established in 1969 in the United Kingdom. It has deep roots internationally across North America, EMEA and APAC. The company has made several acquisitions, including Xybion and RockStep Solutions, and has unified acquisitions under the Instem brand. It also relaunched the d-wise brand and announced new global headquarters in Boston, MA.

• 2021.09.02

  Reported2021.09.02

  Instem acquires PDS Pathology Data Systems[5]Instem 收购 PDS Pathology Data Systemsthemarketreporter.co.uk

  Instem announced its acquisition of Swiss competitor PDS Pathology Data Systems for CHF 14.25 million (£11.4 million); the deal was expected to be immediately earnings-enhancing.

• 2021.09.01

  Reported2021.09.01

  Instem acquires PDS Life Sciences[6]Instem收购PDS Life Sciencesfinanznachrichten.de

  Instem announced that it had acquired PDS Life Sciences. The acquisition expands Instem's capabilities in non-clinical study management and regulatory submissions.

Read more

1. 1Life Science Software – Drug Research & Development | Insteminstem.com
2. 2About Us - Life Science Software – Drug Research & Developmentinstem.com
3. 3Company News - Life Science Software – Drug Research & Developmentinstem.com
4. 4Leadership - Life Science Software – Drug Research & Developmentinstem.com
5. 5Instem 收购 PDS Pathology Data Systemsthemarketreporter.co.uk
6. 6Instem收购PDS Life Sciencesfinanznachrichten.de